-
Kentucky’s screening improvement drives drop in late-stage lung cancer (University of Kentucky)
Inbox
18 Nov 2025 20:38 GMT
LEXINGTON, Ky. Kentucky has historically led the nation in lung cancer rates, but the statistics are turning around thanks to a decade-long statewide effort to engage more people in screening.
Kentucky’s lung cancer screening rates have improved …
-
Kentucky’s screening improvement drives drop in late-stage lung cancer
17 Nov 2025 10:46 GMT
LEXINGTON, Ky. (Nov. 17, 2025) — Kentucky has historically led the nation in lung cancer rates, but the statistics are turning around thanks to a decade-long statewide effort to engage more people in screening.
Kentucky’s lung cancer screening rates have …
-
Who is most at risk for lung cancer?
15 Nov 2025 11:19 GMT
Lung cancer is the leading cause of cancer deaths in the United States, and the second most common cancer diagnosis, according to the National Cancer Institute.
Smoking is the number one risk factor for lung cancer, but it’s certainly not the only cause. …
-
Personalized mRNA Vaccines Will Revolutionize Cancer Treatment—If Federal Funding Cuts Don’t Doom Them
19 Nov 2025 00:19 GMT
As soon as Barbara Brigham’s cancerous pancreatic tumor was removed from her body in the fall of 2020, the buzz of a pager summoned a researcher to the pathology department in Memorial Sloan Kettering’s main hospital in New York City, one floor below. …
-
DeepTarget tool helps identify secondary cancer drug targets
18 Nov 2025 16:33 GMT
… during his training at the National Cancer Institute. He developed a computational tool … (BTK), not being present in lung tumours.
Cells carrying the mutant EGFR …
-
[Latest] Global NUT Midline Carcinoma Treatment Market Size/Share Worth USD 93.34 Billion by 2034 at a 15.26% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
18 Nov 2025 08:30 GMT
Austin, TX, USA, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “NUT Midline Carcinoma Treatment Market Size, Trends and Insights By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation …
-
<![CDATA[Chemoradiotherapy Improved Survival in Older Patients With Stage 2 NSCLC]]>
16 Nov 2025 21:24 GMT
… End Results database from the National Cancer Institute was used for this study … /6203-non-small-cell-lung-cancer
3. Key statistics for lung … /cancer/types/lung-cancer/about/key-statistics …
-
Exploring New Frontiers in Cancer Drug Targets Through Computational Deep Dive
15 Nov 2025 04:35 GMT
… as the relevant targets in lung tumors, a hypothesis confirmed by the … a multidisciplinary consortium including the National Cancer Institute and Tel Aviv University, exemplifies …
-
Computational Deep Dive Surfaces Unexplored World of Cancer Drug Targets
15 Nov 2025 01:59 GMT
… time training at the National Cancer Institute, Sinha has investigated … is not present in lung tumors.
In collaboration with … Lab at the National Cancer Institute, is the senior … Institutes of Health, National Cancer Institute and Sanford Burnham Prebys …
-
DeepTarget: A new tool for drug repurposing in oncology
14 Nov 2025 19:38 GMT
… his time training at the National Cancer Institute, Sinha has investigated the malleability … (BTK)-is not present in lung tumors.
In collaboration with the lab …
About
© 1995-2025